Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

65--Pharm Manuf/Distr Div - FSA

Awarded
SPE2D225R0020Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Solicitation SPE2D225R0020 is a request for proposal issued by the Defense Logistics Agency Troop Support, specifically through the Pharmaceutical Manufacturing and Distribution Division, for a national contract to procure Rasagiline. This unrestricted procurement effort, categorized under NAICS code 325411, involves the delivery of pharmaceutical products to DLA and VA pharmaceutical prime vendors. The solicitation was issued on September 4, 2025, with a submission deadline for offers set for October 6, 2025. The contract is managed by the Department of Defense office located in Philadelphia, Pennsylvania, with Jason C. Wray serving as the primary point of contact. The procurement process follows FAR and DFARS regulations for commercial items and includes a comprehensive statement of work detailing the background, purpose, and delivery requirements. Evaluation criteria and specific contract clauses are outlined within the solicitation to ensure the fulfillment of national pharmaceutical needs.

General Info

Contract Value

$6,637,357.21

NAICS

325411 - Medicinal and Botanical Manufacturing

Place of Performance

PA

Set-Aside

NONE

Award Issued Date

Documents

1

Solicitation SPE2D2-25-R-0020 for Rasagiline National Contract

PDF, High priority: read this firstrfp
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
Contacts1 person available
OfficePHILADELPHIA, PA, 19111, USA
Office AddressPHILADELPHIA, PA, 19111, USA

Full Description

Show more
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rasagiline Tablets. Procurement details follow. Rasagiline 0.5 MG Tablet and Rasagiline 1 MG Tablet in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Kyle Lewicki at +1 (555) 000-0000, (contact@example.gov) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is August of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

Similar Contracts

Same NAICS industry code

NAICS: 325411
Federal
NOI - B2B Award entitled - Developing Red Cell-Sp
Solicitation # 75N98027Q00017
Solicitation 75N98027Q00017 is a combined synopsis and notice of intent for a non-competitive award by the National Institutes of Health (NIH) to Purdue University, specifically the Purdue Institute for Drug Discovery. The contract supports the Bench-to-Bedside study Developing Red Cell-Specific Spleen Tyrosine Kinase (SYK) Inhibitors for Treating Sickle Cell Disease. The scope of work for the Year 1 requirement involves the synthesis, scale-up, characterization, and optimization of lead SYK inhibitors S1115 and S1213, with a delivery requirement of approximately 3 to 5 grams of each compound along with supporting analytical and potency data. The award is justified as non-competitive because Purdue University possesses the project-specific knowledge and prior research experience necessary to avoid technical risk and duplication of effort. The acquisition is conducted under FAR 12.603 for commercial items and is not expected to exceed the simplified acquisition threshold. Research activities will be performed at Purdue University in West Lafayette, Indiana, with deliverables sent to the National Heart, Lung, and Blood Institute in Bethesda, Maryland. The associated NAICS code is 325411 for Medicinal and Botanical Manufacturing, and the requirement is not set aside for small businesses. Administrative requirements include active registration in the System for Award Management and the use of the Invoicing Processing Platform for three-way match payments. Responses were due by November 4, 2026, to the contracting specialist, Nicholas Capobianco.
National Institutes Of Health Olao

POSTED

9 days ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → DLA Troop Support

Same awarding agency

NAICS: 326199
New
Federal
Synopsis for Outserts (NSN - 4240-01-529-8327 & 4240-01-528-9288)
Solicitation # 015298327_015289288
Solicitation SPE8EG-26-R-0003 is an unrestricted, fixed-price with economic price adjustment, indefinite delivery/indefinite quantity contract issued by DLA Troop Support. The procurement is for critical Chemical Biological Radiation and Nuclear Personal Protective Equipment, specifically Clear Assembly Outserts (NSN 4240-01-529-8327) and Laser Assembly Outserts (NSN 4240-01-528-9288). The contract structure consists of a one-year base period and four one-year option periods, with a target delivery schedule of 100 days and terms set as FOB Origin. Avon Protection Systems Incorporated is the approved source, and while alternate offers are encouraged via specific DLAD procurement notes, they require a complete data package for evaluation. The solicitation has undergone five amendments, with the final closing date extended to September 2, 2026, at 3:00 PM EDT. Key regulatory requirements include compliance with the Buy American Act, the Berry Amendment, and export-control regulations under ITAR and EAR, requiring offerors to have approved US/Canada Joint Certification Program certification. Additionally, the contract incorporates FAR 52.222-90 regarding DEI discrimination and clarifies that while Cybersecurity Maturity Model Certification Level 2 is not required for the initial award, it may be necessary for future continued performance. Price is the sole evaluated factor for award.
All Other Plastics Product Manufacturing

POSTED

about 19 hours ago

DEADLINE

in 16 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS